Free Trial
LON:OXB

Oxford Biomedica (OXB) Share Price, News & Analysis

Oxford Biomedica logo
GBX 571 +14.00 (+2.51%)
As of 12:23 PM Eastern

About Oxford Biomedica Stock (LON:OXB)

Key Stats

Today's Range
559
578.16
50-Day Range
307
571
52-Week Range
232.50
578.16
Volume
411,274 shs
Average Volume
231,054 shs
Market Capitalization
£606.98 million
P/E Ratio
N/A
Dividend Yield
4.57%
Price Target
GBX 540.25
Consensus Rating
Moderate Buy

Company Overview

Oxford Biomedica Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

OXB MarketRank™: 

Oxford Biomedica scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Oxford Biomedica has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Oxford Biomedica has only been the subject of 3 research reports in the past 90 days.

  • Read more about Oxford Biomedica's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Oxford Biomedica is -4.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Oxford Biomedica is -4.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Oxford Biomedica has a P/B Ratio of 8.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for OXB.
  • Dividend Leadership

    Oxford Biomedica is a leading dividend payer. It pays a dividend yield of 4.57%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Oxford Biomedica does not have a long track record of dividend growth.

  • Read more about Oxford Biomedica's dividend.
  • Short Interest

    There is no current short interest data available for OXB.
  • News Sentiment

    Oxford Biomedica has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Oxford Biomedica this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for OXB on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Oxford Biomedica to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Oxford Biomedica insiders have bought 1,383.24% more of their company's stock than they have sold. Specifically, they have bought £338,400.36 in company stock and sold £22,815 in company stock.

  • Percentage Held by Insiders

    21.17% of the stock of Oxford Biomedica is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    64.13% of the stock of Oxford Biomedica is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Oxford Biomedica's insider trading history.
Receive OXB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OXB Stock News Headlines

What Are Some Strategies to Help Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.tc pixel
Oxford Biomedica (LON:OXB) Insider Purchases £301,500 in Stock
Oxford Biomedica (LON:OXB) Trading 12.5% Higher - Here's Why
UK's Oxford Biomedica maintains annual outlook
See More Headlines

OXB Stock Analysis - Frequently Asked Questions

Oxford Biomedica's stock was trading at GBX 420 at the beginning of the year. Since then, OXB stock has increased by 36.0% and is now trading at GBX 571.

Oxford Biomedica plc (LON:OXB) issued its earnings results on Wednesday, April, 9th. The biopharmaceutical company reported ($41.75) earnings per share for the quarter. Oxford Biomedica had a negative net margin of 145.98% and a negative trailing twelve-month return on equity of 202.50%.
Read the conference call transcript
.

Shares of OXB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford Biomedica investors own include EnQuest (ENQ), Petra Diamonds (PDL), Sirius Minerals (SXX), Centamin (CEY), Lloyds Banking Group (LLOY), Oxford BioMedica (OXBDF) and Barclays (BARC).

Company Calendar

Last Earnings
4/09/2025
Today
8/28/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:OXB
CIK
N/A
Fax
N/A
Employees
891
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 930
Low Price Target
GBX 380
Potential Upside/Downside
-5.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (134.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£143.51 million
Net Margins
-145.98%
Pretax Margin
N/A
Return on Equity
-202.50%
Return on Assets
-12.67%

Debt

Debt-to-Equity Ratio
166.48
Current Ratio
2.35
Quick Ratio
1.67

Sales & Book Value

Annual Sales
£98.31 million
Price / Sales
6.17
Cash Flow
GBX 189.92 per share
Price / Cash Flow
3.01
Book Value
GBX 67.70 per share
Price / Book
8.43

Miscellaneous

Outstanding Shares
106,301,077
Free Float
N/A
Market Cap
£606.98 million
Optionable
Not Optionable
Beta
1.09
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (LON:OXB) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners